XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Income and Comprehensive Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Revenues $ 387.9 $ 296.0 $ 1,076.7 $ 821.5
Operating expenses:        
Cost of revenues 6.1 4.2 15.5 10.2
Research and development 107.7 92.7 345.8 240.7
Acquired in-process research and development 0.0 0.0 0.0 5.0
Selling, general and administrative 186.3 154.6 569.8 426.8
Total operating expenses 300.1 251.5 931.1 682.7
Operating income 87.8 44.5 145.6 138.8
Other income (expense):        
Interest expense (1.2) (6.6) (6.0) (19.2)
Unrealized gain (loss) on equity securities 11.1 (8.2) 23.6 (7.5)
Loss on extinguishment of convertible senior notes 0.0 0.0 (70.0) 0.0
Investment income and other, net 0.2 0.8 2.8 3.1
Total other income (expense), net 10.1 (14.0) (49.6) (23.6)
Income before provision for income taxes 97.9 30.5 96.0 115.2
Provision for income taxes 29.4 8.0 30.5 18.3
Net income 68.5 22.5 65.5 96.9
Unrealized loss on debt securities available-for-sale, net of tax (1.8) (0.3) (12.3) (1.4)
Comprehensive income $ 66.7 $ 22.2 $ 53.2 $ 95.5
Earnings per share:        
Basic (in USD per share) $ 0.72 $ 0.24 $ 0.69 $ 1.03
Diluted (in USD per share) $ 0.69 $ 0.23 $ 0.67 $ 0.99
Weighted-average shares outstanding:        
Basic (in shares) 95.8 94.7 95.6 94.5
Diluted (in shares) 99.0 97.7 98.3 97.9
Net product sales        
Revenues:        
Revenues $ 379.3 $ 288.8 $ 1,036.3 $ 786.6
Collaboration revenues        
Revenues:        
Revenues $ 8.6 $ 7.2 $ 40.4 $ 34.9